NLRP3 and cryopyrin-associated periodic syndrome: The conclusions of our study are reinforced by previous research that identified activation of the NLRP3 in unprimed primary PBMCs from CAPS patients and in recombinant THP-1 cells expressing mutant NLRP338–41.